BioLine Innovations Jerusalem LP
BioLineRx's pre-clinical drug development program is referred to as BioLine Innovations Jerusalem (BIJ), and is supported by the Israeli Office of the Chief Scientist's national biotechnology initiative. As the only biotechnology-dedicated incubator, BIJ is uniquely positioned to take early stage compounds through rigorous pre-clinical tests on their way to clinical trials.
|Dr. Leah Klapper|
|19 Hartum Street, P.O. Box 45158, Jerusalem 91450, Israel|
To update your company data, click here.